ABG Q1 2026 Earnings Earnings Miss Estimates Despite Positive Stock Movement Halozyme Therapeutics Inc HALO Q1 2026 Earnings EPS Surpasses Estimates Despite Flat Revenue Disclosure PRIM Q1 2026 Earnings EPS Misses Estimate by 315 Stock Still Climbs 69 IART Q1 2026 Earnings Strong EPS Beat Drives Modest Stock Gain SLRC Q1 2026 Earnings Investment Income Misses Expectations as Stock Declines QCLS Q4 2017 Earnings Massive EPS Miss with Negative Earnings Despite Stock Rise